-
1. Federation Bio Administers First Dose in Phase 1 Clinical Trial
Link: https://www.prnewswire.com/news-releases/federation-bio-administers-first-dose-in-phase-1-clinical-trial-evaluating-investigational-bacterial-cell-therapy-301697583.html
Description: WebDec 8, 2022 · SOUTH SAN FRANCISCO, Calif., Dec. 8, 2022 /PRNewswire/ -- Federation Bio, a biotechnology company pioneering bacterial cell therapies, today announced that investigators have …
-
2. Federation Bio Launches with $50 Million Series A Financing and Exp…
Link: https://www.prnewswire.com/news-releases/federation-bio-launches-with-50-million-series-a-financing-and-expands-team-to-pioneer-diverse-microbial-therapies-301146266.html
Description: WebOct 6, 2020 · Federation Bio is pioneering new approaches for treating intractable diseases by combining an unprecedented number of microbial strains into highly diverse consortia, in some instances …
-
3. Federation Bio: from single strains to a purely synthetic microbiome
Link: https://www.nature.com/articles/d41587-021-00009-3
Description: WebJun 30, 2021 · Federation Bio: from single strains to a purely synthetic microbiome. Engineered single-strain biotherapeutic products and massive synthetic consortia are being developed in …
-
4. MD Anderson and Federation Bio Announce Collaboration to Develo…
Link: https://www.prnewswire.com/news-releases/md-anderson-and-federation-bio-announce-collaboration-to-develop-novel-microbiome-treatment-for-patients-with-immunotherapy-resistant-cancers-301735283.html
Description: WebFeb 1, 2023 · Federation Bio is a biopharmaceutical company pioneering novel bacterial cell therapies to treat a wide range of intractable diseases – from metabolic disorders to metastatic …
-
5. Federation Bio goes live with $50M to pursue microbial treatments
Link: https://www.fiercebiotech.com/biotech/federation-bio-launches-50m-to-pursue-microbial-treatments
Description: WebOct 6, 2020 · One company, Federation Bio, thinks its approach can top the rest, and its new CEO—not to mention investors—agree. The company launches with $50 million and science so …